199 related articles for article (PubMed ID: 12610739)
21. Quinine pharmacokinetics: ototoxic and cardiotoxic effects in healthy Caucasian subjects and in patients with falciparum malaria.
Claessen FA; van Boxtel CJ; Perenboom RM; Tange RA; Wetsteijn JC; Kager PA
Trop Med Int Health; 1998 Jun; 3(6):482-9. PubMed ID: 9657511
[TBL] [Abstract][Full Text] [Related]
22. Quinine pharmacokinetics and pharmacodynamics in children with malaria caused by Plasmodium falciparum.
Le Jouan M; Jullien V; Tetanye E; Tran A; Rey E; Tréluyer JM; Tod M; Pons G
Antimicrob Agents Chemother; 2005 Sep; 49(9):3658-62. PubMed ID: 16127036
[TBL] [Abstract][Full Text] [Related]
23. Effects of cigarette smoking on quinine pharmacokinetics in malaria.
Pukrittayakamee S; Pitisuttithum P; Zhang H; Jantra A; Wanwimolruk S; White NJ
Eur J Clin Pharmacol; 2002 Aug; 58(5):315-9. PubMed ID: 12185554
[TBL] [Abstract][Full Text] [Related]
24. A randomized trial of the efficacy of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital, Cameroon.
Maka DE; Chiabi A; Ndikum V; Achu D; Mah E; Nguefack S; Nana P; Njoumemi Z; Mbacham W; Mbonda E
Malar J; 2015 Oct; 14():429. PubMed ID: 26520401
[TBL] [Abstract][Full Text] [Related]
25. An open randomized clinical study of intrarectal versus infused Quinimax for the treatment of childhood cerebral malaria in Niger.
Barennes H; Munjakazi J; Verdier F; Clavier F; Pussard E
Trans R Soc Trop Med Hyg; 1998; 92(4):437-40. PubMed ID: 9850403
[TBL] [Abstract][Full Text] [Related]
26. [Tolerance of quinine administered as an intrarectal solution in children in French-speaking Africa].
Barennes H; Mahaman Sani A; Kahia Tani F; Meda H; Khenine A
Med Trop (Mars); 1999; 59(4):383-8. PubMed ID: 10816754
[TBL] [Abstract][Full Text] [Related]
27. Quinine pharmacokinetics in young children with severe malaria.
van Hensbroek MB; Kwiatkowski D; van den Berg B; Hoek FJ; van Boxtel CJ; Kager PA
Am J Trop Med Hyg; 1996 Mar; 54(3):237-42. PubMed ID: 8600757
[TBL] [Abstract][Full Text] [Related]
28. Quinine levels revisited: the value of routine drug level monitoring for those on parenteral therapy.
Flanagan KL; Buckley-Sharp M; Doherty T; Whitty CJ
Acta Trop; 2006 Feb; 97(2):233-7. PubMed ID: 16387280
[TBL] [Abstract][Full Text] [Related]
29. Absolute bioavailability of quinine formulations in Nigeria.
Babalola CP; Bolaji OO; Ogunbona FA; Ezeomah E
Afr J Med Med Sci; 2004 Sep; 33(3):185-9. PubMed ID: 15819461
[TBL] [Abstract][Full Text] [Related]
30. Population pharmacokinetic and pharmacodynamic properties of intramuscular quinine in Tanzanian children with severe Falciparum malaria.
Hendriksen IC; Maiga D; Lemnge MM; Mtove G; Gesase S; Reyburn H; Lindegardh N; Day NP; von Seidlein L; Dondorp AM; Tarning J; White NJ
Antimicrob Agents Chemother; 2013 Feb; 57(2):775-83. PubMed ID: 23183442
[TBL] [Abstract][Full Text] [Related]
31. [Diluted injectable quinine in the intramuscular and intrarectal route: comparative efficacity and tolerance in malaria treatment for children ].
Assimadi JK; Gbadoe AD; Agbodjan-Djossou O; Larsen SE; Kusiaku K; Lawson-Evi K; Rédah D; Adjogblé A; Gayibor A
Med Trop (Mars); 2002; 62(2):158-62. PubMed ID: 12192713
[TBL] [Abstract][Full Text] [Related]
32. The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children.
Ogutu BR; Nzila AM; Ochong E; Mithwani S; Wamola B; Olola CH; Lowe B; Kokwaro GO; Marsh K; Newton CR
Trop Med Int Health; 2005 May; 10(5):484-8. PubMed ID: 15860096
[TBL] [Abstract][Full Text] [Related]
33. Oral quinine pharmacokinetics and dietary salt intake.
Newton P; Simpson A; Wanwimolruk S; Maliakal P; Villegas L; Kuypers D; White NJ
Eur J Clin Pharmacol; 2001 May; 57(2):111-3. PubMed ID: 11417441
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of quinine, quinidine and Cinchonine when given as combination.
Karbwang J; Bunnag D; Harinasuta T; Chittamas S; Berth J; Druilhe P
Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):773-6. PubMed ID: 1298088
[TBL] [Abstract][Full Text] [Related]
35. Early treatment failure in severe malaria resulting from abnormally low plasma quinine concentrations.
Newton PN; Ward S; Angus BJ; Chierakul W; Dondorp A; Ruangveerayuth R; Silamut K; Teerapong P; Suputtamongkol Y; Looareesuwan S; White NJ
Trans R Soc Trop Med Hyg; 2006 Feb; 100(2):184-6. PubMed ID: 16289166
[TBL] [Abstract][Full Text] [Related]
36. Comparison of artesunate and quinine in the treatment of Sudanese children with severe Plasmodium falciparum malaria.
Eltahir HG; Omer AA; Mohamed AA; Adam I
Trans R Soc Trop Med Hyg; 2010 Oct; 104(10):684-6. PubMed ID: 20850004
[TBL] [Abstract][Full Text] [Related]
37. UK malaria treatment guidelines.
Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of quinine in African patients with acute falciparum malaria.
Babalola CP; Bolaji OO; Ogunbona FA; Sowunmi A; Walker O
Pharm World Sci; 1998 Jun; 20(3):118-22. PubMed ID: 9618735
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children: randomised clinical trial.
Barennes H; Balima-Koussoubé T; Nagot N; Charpentier JC; Pussard E
BMJ; 2006 May; 332(7549):1055-9. PubMed ID: 16675812
[TBL] [Abstract][Full Text] [Related]
40. Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
Kloprogge F; Jullien V; Piola P; Dhorda M; Muwanga S; Nosten F; Day NP; White NJ; Guerin PJ; Tarning J
J Antimicrob Chemother; 2014 Nov; 69(11):3033-40. PubMed ID: 24970740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
